SCHEMBL23994182

SCHEMBL23994182

COc1ncc(-c2cc([C@@H]3C[C@H]3c3ccccn3)c3nccn3n2)c(OC)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 2/20 0.37
▸ PDE10A Q9Y233 8/20 0.37
▸ MTOR P42345 2/20 0.34
▸ ACP1 P24666 1/20 0.34
▸ DPP4 P27487 3/20 0.33
▸ PPARD Q03181 1/20 0.33
▸ QPCT Q16769 1/20 0.32
▸ QPCTL Q9NXS2 1/20 0.32
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ MDM2 Q00987 1/20 0.31
▸ PIK3CD O00329 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ HCK P08631 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ EPHB4 P54760 1/20 0.31
▸ PRKDC P78527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23993986 1.00 SYK (0.37) SYKPDE10AMTORACP1DPP4
SCHEMBL30224492 1.00 SYK (0.37) SYKPDE10AMTORACP1DPP4
SCHEMBL23993918 0.90 SYK (0.38) SYKMTORACP1PPARDQPCT
SCHEMBL25005777 0.89 SYK (0.41) SYKPDE10AMTORACP1PPARD
SCHEMBL30182002 0.89 SYK (0.41) SYKPDE10AMTORACP1PPARD
SCHEMBL23994827 0.89 SYK (0.41) SYKPDE10AMTORACP1PPARD
SCHEMBL23995307 0.88 SYK (0.36) SYKMTORACP1PPARDMDM2
SCHEMBL23995304 0.88 SYK (0.36) SYKMTORACP1PPARDMDM2
SCHEMBL23993481 0.87 MDM2 (0.40) PDE10AMTORMDM2
SCHEMBL23993473 0.87 MDM2 (0.40) PDE10AMTORMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043427-A1 CD73 COMPOUNDS GILEAD SCIENCES, INC. 2024-02-08 — — US disclosed
US-20230039553-A1 CD73 COMPOUNDS GILEAD SCIENCES, INC. 2023-02-09 — — US disclosed
WO-2021222522-A1 CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2021-11-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039553-A1 CD73 COMPOUNDS ENTPD5, ENTPD1, NT5E SYK 2578/4885PDE10A 484/4885MTOR 1667/4885
US-20240043427-A1 CD73 COMPOUNDS ENTPD5, ENTPD1, NT5E SYK 2578/4885PDE10A 484/4885MTOR 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback